Member Info for Saxondale

Looks like the FDA have been caught napping with Cocid-19 . Just today they have changed their policy on companies applying for EUA for testing kits . This is because time is running out and so they have to break their own rules .
So testing kits will be available to be marketed into the US without FDA EUA approval.

I wonder how that may reflect on Farons pending FDA approval for phase III Traumakine and fast track status .

You couldn't set up a scenario more weighted to make this drug any more important .

Next week is going to be interesting thats for sure

Tests kits are available and being sold .
In one way you could say the test kits identify potential Faron customers
Vaccines being worked on - probably 6 months away min - but then that probably won't help you if you already have the virus.
80% will just get mild symptoms
20% will be severe - those ones may need ICU treatment - and many will develop respiratory problems , for which Faron have a drug about to make it to the market .

Fairly calm with holding here , as well up from last week anyway .
A few will be taking profits from latest rise , but so much more to come .
NCYT are booming off back of Covid 19 , as they have an instantly available product that is on the market.
We have a ARDS drug that is nearly on the market - so nobody can buy it today - but look 6 months down the line - I think we will have plenty of customers .

Faron team have 5 conference/investor dates in March - mostly involving Clevegen
Sweden next week , then one in Finland
Progress and updates expected there .
Remember , Traumakine was the sideshow during last year , Clevegen was getting all the attention .
We may get a Clevegen update before Traumakine

Hopefully the FDA will grant Traumakine Fast Track status , not only as it ticks all the boxes regarding safety ( as it has already undergone a phase III trial in 2018 , so they know a lot about the drug , but mainly as now there is a growing worry that ARDS/ respiratory cases may increase exponentially in the next 12 months , and The FDA are getting serious pressure put upon them to act quickly with test kit approvals , and any other related issues that will make them prepared for a sudden upsurge in US cases .

Just got a grand at 3.82
Doing my bit

Good news , that £1k that I sold last week for 2.09 , made 20% !!
I'm trying to ignore the fact that if i'd left it here it would have made 80%
So i sold them and put the £1k back in here at 3.83
What a pro !
Luckily the ask is now 390
Maybe I should write a book ?

Thank goodness she picked that message and not one of Gollums outbursts lol

Funny to think that people who bought this share less than 2 years ago , may well still be 50% down .
At that point we were just about to get the disappointing results from the Traumakine study .
Markuu remained optimistic and pragmatic , even with the destruction of the SP .
They must have been tough times for Faron - failure had never even been considered an option .
But they knew that they had a winner , so just back to work making progress .

Fast forward 20 odd months , the Traumakine results have been explained , protocols agreed , and finally all the FDA requirements have been adhered to .

That alone should bring our value close to the £8 mark .

Then add the fact that we should be moving past where we were back in 2018 - and that the Covid-19 has brought the world to focus on drugs that can help .

Then add in Clevegen , which again on its own could add £8 to the SP just while it is pushing through trials . Even if it only lives up to a 10th of its hype , it will be a major drug .

Then for those wishing to become LTH - we have another Faron invention , yet to hit clinical trials . Going on past history , they don't seem to invent things like cough syrup , so expect something pretty groundbreaking .

So in my opinion , we could get to £5 no probs before the next RNS . Maybe with some spikes and troughs .

After that things are harder to quantify , but with a fairly small free float , things do happen quick .

Biggest issue is trying to decide whether to sell any .
Shouldn't get emotional about a stock , but Faron is a rare company that is doing great things , and looking after shareholders .

Yes well done hasiba , you had an exit strategy and stuck to it .
Whoever buys your shares will enjoy the next leg of the journey .

Nasdaq gone into auction . never followed it closely , so not sure if thats common . volumes are always a lot lower than AIM , but somethings stirring ?

5.38 euro , even at 20% conversion thats £4.50

yep its trading at over 5 euros !

CB Hopefully the lack of RNS from them stating no known reason is a good thing , ie there is a reason.
It could just be the general market piling in to a safe haven / + good prospect
But looking at trades , LSE aren't showing anything from 15.23 onwards - then we get 2 price monitoring RNS after 4.30pm
And the Nasdaq jumps to 4.5 euro at close

What a day ! I'm pretty sure I got a dummy offer for 5000 shares at over £3.70 at one point .
The Nasdaq spiked from 4.2 to 4.5 euro right on the bell .
It was going up like the proverbial firework until they managed to put a lid on it .
Big things to come I think - at this rate it could jump to £4 in any given 30 seconds during trading .
And we haven't even had an update ??

Either way , something has directed the market to look at us .
Corvid-19 related stocks have been rising for last 10 days wildly.
But we are more than just a Coronavirus stock.
Traumakine has been working its way to launch for 7-8 years .
If the launch coincides with a chronic unmet need , for which ARDS currently is , the roll out should be pushed through the FDA procedures with a high priority

No stopping her today . Is this just a wider market thing , or are we on the cusp of some proper RNS news ??

Please remind me never to sell a share out of boredom again .
At least I've made that £3k back again lol

Well the dream is starting to become a reality.
And we haven't actually had any news today.
Like Zen says I expect we will have a few snakes and ladders moments now .
But there seem to be more ladders than snakes
True value is becoming recognised

Well the bid is up to £2.88 at the mo . I can see this moving past £3 purely on investors shifting money into pharma stocks and gold etc . Never mind the fact that we've got huge news too .